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Background: The Cancer Genome Atlas (TCGA) offers a multilayered view of genomics and epigenomics data of
many human cancer types. However, the retrieval of expression and methylation data from TCGA is a cumbersome
and time-consuming task.
Results: Wanderer is an intuitive Web tool allowing real time access and visualization of gene expression and DNA
methylation profiles from TCGA. Given a gene query and selection of a TCGA dataset (e.g., colon adenocarcinomas),
the Web resource provides the expression profile, at the single exon level, and the DNA methylation levels of
HumanMethylation450 BeadChip loci inside or in the vicinity of the queried gene. Graphic and table outputs
include individual and summary data as well as statistical tests, allowing the comparison of tumor and normal
profiles and the exploration along the genomic locus and across tumor collections.
Conclusions: Wanderer offers a simple interface to straightforward access to TCGA data, amenable to experimentalists
and clinicians without bioinformatics expertise. Wanderer may be accessed at http://maplab.cat/wanderer.Background
Cancer includes a group of largely heterogeneous and
complex diseases. The development of massive genomic
analysis techniques and the coordinated effort of different
international consortiums are providing the research com-
munity with comprehensive data of tissue samples from
thousands of cancer patients. Free access to these data
represents an invaluable opportunity for the research
community to get insights into the molecular profiles of
cancers allowing, for instance, identification of new candi-
date markers, in silico hypothesis testing, or validation of
in-house results through an independent series.
Cancer research is benefited by coordinated efforts on
data acquisition and analysis. The Cancer Genome Atlas
(TCGA) [1] is probably the most ambitious of these initia-
tives offering a multilayered view of genomics and epige-
nomics data together with clinicopathological information
of more than 30 human cancer types. Major contributions* Correspondence: map@imppc.org
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creativecommons.org/publicdomain/zero/1.0/of TCGA consortium are illustrated by the opening manu-
scripts (mainly devoted to report the mutational land-
scapes) of each one of the considered human cancers [2];
but a large number of studies are taking advantage of the
available datasets [3].
TCGA Data Portal [4] is the default gateway to retrieve
data offering a text file for each processed sample belong-
ing to a dataset generated using a given platform. Com-
pressed packages for multiple samples are allowed. For
instance, it allows downloading 992 files with the clinical
data related to samples of the Colon Adenocarcinoma
(COAD) dataset, but only provides RNA-Seq results for
303 of them. It is worth noting that as the number of files
and their sizes increase, further processing of this informa-
tion exceeds the spreadsheet-based analysis capabilities
and requires bioinformatics skills.
Cancer research teams working on specific aspects of
the disease (e.g., exploration of candidate biomarkers, de-
regulation of signaling pathways, or mechanisms of gene
regulation, just to name a few) might be more interested
in rapidly querying specific subsets of the data (e.g.,
expression levels of a named gene or the methylation
status of its promoter region) rather than obtainingccess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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the access and exploitation of TCGA data, several tools
have been developed to compare and to explore the differ-
ent levels of data, facilitating the discovery of associations
and correlations, as well as allowing ascertaining the sig-
nificance of certain alterations in cancer [5–7].
The high level of complexity of transcriptomic and
epigenetic profiles in normal and cancer samples poses
challenging scenarios to analyze, represent, and interpret
both gene-specific and bulk data. Important differences
among samples may be easily missed if one-size-fits-all
standardized criteria are used. For instance, gene expres-
sion differences may appear as alternative transcripts and
be missed in summarizing values. Moreover, relevant
DNA methylation changes may occur outside predefined
promoter domains or just affect a subregion.
Here we present Wanderer, a very simple and intuitive
Web tool allowing real-time access and visualization of
gene expression and DNA methylation profiles from
TCGA data using gene targeted queries. Wanderer is
addressed to a broad variety of experimentalists and
clinicians without deep bioinformatics skills.
Results
DNA methylation profiling
For any given gene selected by the investigator, the tool
provides the detailed individual beta values of all the
HumanMethylation450 probes inside or in the vicinity
of the gene. Graphs for normal and tumor samples from
any of the available TCGA datasets are readily produced
(Fig. 1). A summarizing plot is also generated, and statis-
tical comparisons are performed to identify differential
DNA methylation between normal and tumor samples
at the single probe level. Wanderer performs Wilcoxon
rank sum test on normal versus tumor provided there
are at least two observations in each group. Although
this is readily reported, we note that addressing the sig-
nificance on few observations and without inspecting
the data distribution might be meaningless. Even though
the number of samples to draw as line plots can be
modified manually (see below), the statistical analysis is
performed with the complete dataset.
Wanderer complements the DNA methylation profiling
with a tool to overview the influence of DNA methylation
on gene expression. The user is allowed to navigate through
any of the HumanMethylation450 probes located in the
displayed genomic region to explore its correlation with the
gene expression values.
The generated plots and comprehensive tables containing
all the relevant information (individual data, statistical ana-
lyses, and additional clinical data) may be downloaded for
further data analysis or representation with any software
the investigator is used to (e.g., Excel or any other spread-
sheet or graphing tool). In addition, the tool allows localnavigation and zoom in/out within the region of interest as
well as simple graph customization as described below.
Gene expression profiling
For any selected gene, Wanderer displays the expression
of each exon measured as reads per kilobase per million
mapped reads (RPKM) (Fig. 1). A summarizing plot and
statistical analysis is also performed to denote exons
with significant differences between normal and tumor
tissues. Wanderer also represents the summarized gene ex-
pression values in RSEM format (RNA-Seq by Expectation-
Maximization) [8] as a boxplot and a scatterplot for normal
and tumor samples. A Wilcoxon rank sum test checks
whether normal and tumors are statistically equivalent.
Similarly to the DNA methylation profiling, gene ex-
pression graphs can be modified using predefined op-
tions (see below). Finally, the plots and gene expression
data may be downloaded as files in compatible formats
for further analysis and representation.
Plotting versatility
Graphical outputs are highly dynamic, being rendered
on the fly. Once the gene of interest is selected, some
parameters can be easily tuned:
 The user can zoom in and out either by using a
simple slider or entering a custom coordinate range
by hand.
 A glyph depicting the actual gene location and
transcription direction may be optionally shown.
 Methylation probes belonging to a CpG island can
be highlighted in green.
 Distance between probes or exons can be selected to
be proportional to the actual genomic location or to
be uniform. In the case of methylation, this feature
facilitates visualization of regions with high density
of probes, such as CpG islands.
 Individual DNA methylation and gene expression
profiles are drawn as line plots by default. In this
representation, the scrutinized exons or CpGs
belonging to the same sample are connected by
lines. The user can modify the number of samples to
be represented this way. A random sampling (with a
random seed so the result is repeatable) is therefore
performed. However, all the data can be taken into
account at once ticking the “Boxplot all the data”
checkbox.
 The user can select the p value threshold by exon or
by CpG normal vs tumor comparison.
Further capabilities
Data, analysis, and graphics may be downloaded as differ-
ent files packaged in a single ZIP-compressed archive.
This archive is named with a unique identifier containing
Fig. 1 Snapshot of Wanderer Web page. Illustrative example of the DNA methylation (left window) and gene expression profiles (right window)
associated with MLH1 gene in colon cancer dataset. The left panel in each window includes data selection (gene name/ID and dataset) and view
customization parameters (graphics options, statistical threshold, etc.). The right panel of each window displays individual and summarized profiles for
normal and tumor samples. The DNA methylation window allows interrogating the correlation between DNA methylation of individual probes with
gene expression. At the bottom of the window, direct links provide data download and customized access to other Web portals containing TCGA data
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are provided in raster (PNG) and vector (PDF) formats.
Probe annotations, statistical analysis, and clinical and raw
data for both normal and tumor samples are available
as text files (comma-separated values (CSV)) that can
be processed using spreadsheet software. The ZIP file
also includes the user manual with a detailed summary
of the outputs and the software and data version.Wanderer also offers batch analysis capabilities as well
data sharing and linking from other Web resources
through a Wanderer application programming interface
(API) [9]. Wanderer API has the same capabilities as
Wanderer but receives the parameters parsing arguments
from the URL.
The tool provides deep links to explore additional
information regarding the preselected gene and TCGA
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tions, protein and survival data, among others; the All
Pairs Regulome Explorer [11] presents an interactive
visualization of associations between the region of interest
and different types of data including mutations, copy
number alterations, or clinical information; and finally, a
link to the UCSC Genome Browser [12] allows a genomic
view of the scrutinized region.
Usage examples
Below we report three queries illustrating issues that can
be easily resolved by Wanderer, but requiring a large
number of steps and/or computational skills to be
achieved by other means.
 Gene expression profiles. Are different samples
expressing the same gene isoforms? Which exon(s)
should I analyze to find the largest difference
between normal and tumor? As shown in Fig. 2, the
abundance of the different exons of the SLC39A14
gene (also known as zinc transporter ZIP14) shows
an uneven balance in normal and tumor tissues in
colon cancer patients. These differences are
explained by the predominance of the transcript
containing exon 4A in normal colon, while cancer
cells display an alternative splicing with increased
representation of exon 4B [13]. Interestingly, the
colon cancer profile is similar to the one present in
lung (Fig. 2, right panel) and other tissues (data not
shown), with no differences between normal and
tumor tissues.
 DNA methylation profiles. Which region of the CpG
island should I analyze to find the largest abnormal
DNA methylation in tumor samples? Is it the same
for different tumor types? As shown in Fig. 3a,
the PTGIS CpG island is represented by five
HumanMethylation450 BeadChip probes. A high
proportion of colon tumors show hypermethylation
of the CpG island, but the one that is farther from
the TSS (denoted with an arrowhead) is already
partially methylated in normal tissue and therefore
is the less discriminative one. On the contrary, this
position remains fully unmethylated in most normal
prostate tissues, but is highly hypermethylated in
prostate cancer. PTGIS is downregulated in both
colon and prostate cancer (Fig. 3b).
 DNA methylation profiles. What is the extent
of DNA methylation changes in regard to a
specific gene? EN1 CpG island is frequently
hypermethylated in both colorectal and breast
cancer (Fig. 4a). Nevertheless, when zooming out
to the flanking regions (Fig. 4b), the profiles
clearly show that hypermethylation affects many
neighboring CpG islands in colon cancer but not inbreast cancer, where hypermethylation is restricted
to the EN1 CpG island (denoted by an arrowhead).
Discussion
Integration and mining of TCGA data is a hot topic in
clinical bioinformatics. Given the massive nature of data,
some of the tools are primarily focused on data retrieval,
such as TCGA-Assembler [14], and further annotation
and indexing, such as Firehose [15]. A second group of
analytical platforms are devoted to provide a compre-
hensive view of the multiple layers of TCGA by linking
molecular data to the clinical features. An outstanding
example is cBioPortal [10], which delivers multiple out-
puts including survival analysis. Regulome Explorer [11]
shows associations between clinical and molecular fea-
tures and provides a circular-based visualization of the
data, among others. The Cancer Genome Workbench
(CGWB) [16] provides many interfaces to integrate and
visualize multiple layers of data. Finally, other tools with
a broader scope, as the UCSC Genome Browser, have in-
corporated TCGA data allowing genomic coordinate-
based display [17]. A comprehensive list of cancer data
visualization tools may be found at TCGA website [18]
and recent reviews [5, 6].
These ambitious initiatives are invaluable contribu-
tions which facilitate the access and analysis of the
vast amounts of data; but they may be deceiving to
wet lab researchers and clinicians with limited compu-
tational skills and who are just willing to query very
specific information. To face these needs, some tools
have been developed providing a very simple interface
specialized in a few layers of information. Remarkable
examples are MethHC [19] and MENT [20], mainly
focused on the comparison of gene expression and
DNA methylation.
Wanderer offers a gene-centered access to gene ex-
pression and DNA methylation TCGA data. The most
outstanding and differential feature of this tool is data
display and analysis in a regional framework. The intui-
tive, simple, and interactive interface facilitates the
visualization, interpretation, and obtention of otherwise
complex information not easily reachable in other pack-
ages. Direct view of the expression and DNA methyla-
tion profiles in a regional context may have important
applications as illustrated by the usage examples re-
ported above. A quick view of the profile in a specific
dataset should be extremely useful to design the most
appropriate strategy (i.e., choosing the region or the
probe to be analyzed) to determine either the expression
of the DNA methylation of a given gene in an experi-
mental setting. These scenarios are common in molecu-
lar studies, and the utility of the information is not
limited to cancer research. Basic and clinical researchers
working in any field of human biology may be also
Fig. 2 Gene expression profile of SLC39A14 in colon adenocarcinoma (COAD) and lung adenocarcinoma (LUAD). The SLC39A14 gene shows a
different expression profile between normal and tumor colon, with most marked differences in the region denoted by a box. In contrast, lung
normal and malignant tissues display similar profiles. The bottom panel shows SLC39A14 isoforms of in the UCSC genome browser window and
the arrows point the location of alternatively spliced exons 4A and 4B
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Fig. 3 DNA methylation and gene expression of PTGIS. a DNA methylation profile of PTGIS CpG island in colon adenocarcinomas (COAD) and
prostate adenocarcinomas (PRAD). Note that cg1077290 probe (denoted by an arrowhead) is already very methylated in colon normal tissue,
offering poor discriminative resolution to detect tumor hypermethylation compared with the rest of CpG island probes (labeled in green). In
contrast, this probe (cg1077290) shows the highest level of hypermethylation in prostate cancers (PRAD) and remains unmethylated in normal
tissue, resulting as the most discriminant variable in this type of cancer. b Overall gene expression of PTGIS gene in colon and prostate samples
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especially in normal tissues.
Another important feature provided by Wanderer is
the simple interface to download small subsets of data in
a format easily amenable for customized statistical and
graphical analyses. Any user with average proficiency in
office suites (Microsoft Office, OpenOffice, IWorks, etc.)
or statistics packages (SPSS, SAS, R, etc.) can obtain thedesired dataset in a compatible format by just by press-
ing a button.
Conclusions
Wanderer is an intuitive interface to explore and inter-
pret gene-associated profiles of expression and DNA
methylation for all the cancer types available at TCGA.
Normal-tumor paired comparisons are readily provided
Fig. 4 DNA methylation profile of the EN1 gene CpG island and flanking regions in colon (COAD) and breast carcinomas (BRCA). a Individual
and mean methylation beta values of EN1 CpG island and the adjacent CpGs (chr2: 119,604,000–119,606,000). The region remains unmethylated
in normal tissues and becomes hypermethylated in both colon and breast cancers. b Zooming out the region (chr2: 119,540,000–119,706,000)
reveals the presence of a large number of CpG islands (green probes) and global hypermethylation of most of them in colon adenocarcinomas.
Alternatively, breast cancers display interspersed regions of hypomethylation and hypermethylation. The graphs display the average methylation
values of each dataset. Probes marked with an asterisk denote statistically significant differences between normal and tumor samples. Arrowheads
indicate the position of the EN1 CpG island probes
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the selection of candidate loci to be considered in experi-
mental and statistical settings. The outputs may be down-
loaded and shared via API. Wanderer is freely accessible at
http://maplab.cat/wanderer.
Methods
The user-friendly Web application has been developed
using R/shiny and a PostgreSQL backend using an eXtremeprogramming software development methodology. Wan-
derer is compatible with most common Web browsers and
operative systems, requires no installation, and can be run
on commodity computers, such as low-memory laptops.
Data consists of HumanMethylation450 BeadChip
and Illumina HiSeq exon and gene quantifications as com-
puted by the RNA-Seq Version 2 pipeline. Data was
downloaded with TCGA-Assembler [14]. Source code is
available under the GPL v2 terms at [21].
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